Alexander Hogrebe

Alexander Hogrebe

Auto-generated profile, based on publicly available information

Alexander Hogrebe

MSAID Gmbh

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DBDorte B. Bekker-Jensen
Dorte B. Bekker-Jensen
OBOliver M. Bernhardt
Oliver M. Bernhardt
AHAlexander Hogrebe
Alexander Hogrebe
AMAna Martinez-Val
Ana Martinez-Val
LVLynn Verbeke
Lynn Verbeke
JOJesper V. Olsen
Jesper V. Olsen
Quantitative phosphoproteomics has transformed investigations of cell signaling, but it remains challenging to scale the technology for high-throughput analyses. Here we report a rapid and reproducible approach to analyze hundreds of phosphoproteomes using data-independent acquisition (DIA) with an accurate site localization score incorporated into Spectronaut. DIA-based phosphoproteomics achieves an order of magnitude broader dynamic range, higher reproducibility of identification, and improved sensitivity and accuracy of quantification compared to state-of-the-art data-dependent acquisition (DDA)-based phosphoproteomics. Notably, direct DIA without the need of spectral libraries performs close to analyses using project-specific libraries, quantifying > 20,000 phosphopeptides in 15 min single-shot LC-MS analysis per condition. Adaptation of a 3D multiple regression model-based algorithm enables global determination of phosphorylation site stoichiometry in DIA. Scalability of the DIA approach is demonstrated by systematically analyzing the effects of thirty kinase inhibitors in context of epidermal growth factor (EGF) signaling showing that specific protein kinases mediate EGF-dependent phospho-regulation.

13 March 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AHAlexander Hogrebe
Alexander Hogrebe
LSLouise von Stechow
Louise von Stechow
DBDorte B. Bekker-Jensen
Dorte B. Bekker-Jensen
BWBrian T. Weinert
Brian T. Weinert
CKChristian D. Kelstrup
Christian D. Kelstrup
JOJesper V. Olsen
Jesper V. Olsen
Comprehensive mass spectrometry (MS)-based proteomics is now feasible, but reproducible quantification remains challenging, especially for post-translational modifications such as phosphorylation. Here, we compare the most popular quantification techniques for global phosphoproteomics: label-free quantification (LFQ), stable isotope labeling by amino acids in cell culture (SILAC) and MS2- and MS3-measured tandem mass tags (TMT). In a mixed species comparison with fixed phosphopeptide ratios, we find LFQ and SILAC to be the most accurate techniques. MS2-based TMT yields the highest precision but lowest accuracy due to ratio compression, which MS3-based TMT can partly rescue. However, MS2-based TMT outperforms MS3-based TMT when analyzing phosphoproteome changes in the DNA damage response, since its higher precision and larger identification numbers allow detection of a greater number of significantly regulated phosphopeptides. Finally, we utilize the TMT multiplexing capabilities to develop an algorithm for determining phosphorylation site stoichiometry, showing that such applications benefit from the high accuracy of MS3-based TMT.

20 December 2017 in Journal of Proteome Research
Verified
Journal Article
Closed access
CKChristian D. Kelstrup
Christian D. Kelstrup
DBDorte B. Bekker-Jensen
Dorte B. Bekker-Jensen
TATabiwang N. Arrey
Tabiwang N. Arrey
AHAlexander Hogrebe
Alexander Hogrebe
AHAlexander Harder
Alexander Harder
JOJesper V. Olsen
Jesper V. Olsen

20 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MFMartin Frejno
Martin Frejno
CMChen Meng
Chen Meng
BRBenjamin Ruprecht
Benjamin Ruprecht
TOThomas Oellerich
Thomas Oellerich
SSSebastian Scheich
Sebastian Scheich
BKBernhard Kuster
Bernhard Kuster
Integrated analysis of genomes, transcriptomes, proteomes and drug responses of cancer cell lines (CCLs) is an emerging approach to uncover molecular mechanisms of drug action. We extend this paradigm to measuring proteome activity landscapes by acquiring and integrating quantitative data for 10,000 proteins and 55,000 phosphorylation sites (p-sites) from 125 CCLs. These data are used to contextualize proteins and p-sites and predict drug sensitivity. For example, we find that Progesterone Receptor (PGR) phosphorylation is associated with sensitivity to drugs modulating estrogen signaling such as Raloxifene. We also demonstrate that Adenylate kinase isoenzyme 1 (AK1) inactivates antimetabolites like Cytarabine. Consequently, high AK1 levels correlate with poor survival of Cytarabine-treated acute myeloid leukemia patients, qualifying AK1 as a patient stratification marker and possibly as a drug target. We provide an interactive web application termed ATLANTiC (http://atlantic.proteomics.wzw.tum.de), which enables the community to explore the thousands of novel functional associations generated by this work.

22 April 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
MFMartin Frejno
Martin Frejno
MBMichelle T. Berger
Michelle T. Berger
JTJohanna Tüshaus
Johanna Tüshaus
AHAlexander Hogrebe
Alexander Hogrebe
FSFlorian Seefried
Florian Seefried
MWMathias Wilhelm
Mathias Wilhelm
Proteomic workflows generate vastly complex peptide mixtures that are analyzed by liquid chromatography–tandem mass spectrometry, creating thousands of spectra, most of which are chimeric and contain fragment ions from more than one peptide. Because of differences in data acquisition strategies such as data-dependent, data-independent or parallel reaction monitoring, separate software packages employing different analysis concepts are used for peptide identification and quantification, even though the underlying information is principally the same. Here, we introduce CHIMERYS, a spectrum-centric search algorithm designed for the deconvolution of chimeric spectra that unifies proteomic data analysis. Using accurate predictions of peptide retention time, fragment ion intensities and applying regularized linear regression, it explains as much fragment ion intensity as possible with as few peptides as possible. Together with rigorous false discovery rate control, CHIMERYS accurately identifies and quantifies multiple peptides per tandem mass spectrum in data-dependent, data-independent or parallel reaction monitoring experiments.

10 September 2024 in The EMBO Journal
Verified
Journal Article
Open access
DBDavid Bradley
David Bradley
AHAlexander Hogrebe
Alexander Hogrebe
RDRohan Dandage
Rohan Dandage
ADAlexandre K Dubé
Alexandre K Dubé
MLMario Leutert
Mario Leutert
CLChristian R Landry
Christian R Landry
The fidelity of signal transduction requires the binding of regulatory molecules to their cognate targets. However, the crowded cell interior risks off-target interactions between proteins that are functionally unrelated. How such off-target interactions impact fitness is not generally known. Here, we use Saccharomyces cerevisiae to inducibly express tyrosine kinases. Because yeast lacks bona fide tyrosine kinases, the resulting tyrosine phosphorylation is biologically spurious. We engineered 44 yeast strains each expressing a tyrosine kinase, and quantitatively analysed their phosphoproteomes. This analysis resulted in ~30,000 phosphosites mapping to ~3500 proteins. The number of spurious pY sites generated correlates strongly with decreased growth, and we predict over 1000 pY events to be deleterious. However, we also find that many of the spurious pY sites have a negligible effect on fitness, possibly because of their low stoichiometry. This result is consistent with our evolutionary analyses demonstrating a lack of phosphotyrosine counter-selection in species with tyrosine kinases. Our results suggest that, alongside the risk for toxicity, the cell can tolerate a large degree of non-functional crosstalk as interaction networks evolve.